Medication info

Clocover Tablet (Clopidogrel Sulfate)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201802249 · Approved 2018.05.30

This product's status changed to Approval withdrawn on 2023.12.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of atherosclerosis symptoms and acute coronary syndrome; prevention of thrombi in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered with this medicine once daily. ○ Patients with renal impairment : Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment : Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be taken with or without food.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of atherosclerosis symptoms and acute coronary syndrome; prevention of thrombi in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-Q wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
View approved original text

This medication is used to improve symptoms caused by atherosclerosis in adult patients with ischemic stroke, myocardial infarction, and peripheral artery disease. It is also effective in reducing the risk of cardiovascular events (such as myocardial infarction and stroke) in patients with acute coronary syndrome who receive drug therapy, coronary intervention, or coronary artery bypass grafting. Additionally, it is used to lower the risk of stroke and thromboembolism in patients with atrial fibrillation who have vascular risk factors, where vitamin K antagonist therapy is not suitable, and where there is a low risk of bleeding. In summary, this medication is used to prevent and improve symptoms related to various cardiovascular diseases and complications associated with the formation of intravascular blood clots.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered with this medicine once daily. ○ Patients with renal impairment : Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment : Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be taken with or without food.

Precautions

This medication prevents platelet aggregation and inhibits blood clotting. Before taking this medication, consult your doctor if you have a genetic deficiency in certain enzymes, as this may reduce the drug's effectiveness. Additionally, it is advisable not to take it with medications that activate certain enzymes, as this may increase drug concentration and the risk of bleeding. This medication should not be taken by those with certain diseases or drug hypersensitivity, those with bleeding, severe liver impairment, those who are breastfeeding, and those with lactose intolerance. Patients at risk of bleeding should use this medication cautiously, and if signs of bleeding appear, they should consult a doctor immediately. Patients scheduled for surgery should discontinue this medication 5-7 days prior to the procedure and also exercise caution when taking it with other medications that carry a bleeding risk. Long-term use may result in side effects such as bleeding, reduction in blood cell counts, gastrointestinal symptoms, and skin rashes, so any unusual symptoms should be reported to healthcare personnel. Pregnant women should only use it when necessary, considering the potential impact on the fetus, and should be cautious due to increased bleeding risk during delivery. If breastfeeding, it is important to consult a doctor regarding whether to continue use, as the drug may be transmitted in breast milk. The safety and efficacy in children have not been established, and elderly patients may require dose adjustments and careful monitoring due to increased bleeding risk associated with diminished bodily functions. In case of overdose, prolonged bleeding time and bleeding complications may occur, and since there are currently no antidotes for this medication, treatment such as platelet transfusion may be necessary in case of bleeding. This medication should be stored out of reach of children, and transferring it to other containers should be avoided as it may pose a risk of accidents and decrease in quality.

Side effects

  • Hemorrhage
  • gastrointestinal bleeding
  • hemorrhage requiring hospitalization
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
Show 142 more
  • intracranial hemorrhage
  • major hemorrhage
  • minor hemorrhage
  • severe hemorrhage
  • fatal hemorrhage
  • hemorrhagic stroke
  • thrombocytopenia
  • neutropenia
  • aplastic anemia
  • abdominal pain
  • dyspepsia
  • diarrhea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • nausea
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • decreased motor function
  • tremor
  • voice disorder
  • abnormal gait
  • hyperkinesia
  • ataxia
  • sensory disturbance
  • constipation
  • ulcer
  • anorexia
  • vomiting
  • hiccups
  • thirst
  • dysphagia
  • tongue disease
  • insomnia
  • depression
  • amnesia
  • anxiety
  • disorientation
  • abnormal behavior
  • rigidity
  • facial edema
  • syncope
  • purpura
  • melena
  • hematoma
  • thrombocytopenia
  • anemia
  • pneumonia
  • sinusitis
  • visual disturbance
  • visual field impairment
  • dry eye syndrome
  • transient blindness
  • congestion
  • tinnitus
  • taste disturbance
  • urination disorder
  • polyuria
  • non-protein nitrogen increase
  • uremia
  • elevated blood urea nitrogen
  • hypoglycemia
  • hyperuricemia
  • elevated liver enzymes
  • ALT elevation
  • liver dysfunction
  • leg edema
  • arrhythmia
  • bradycardia
  • palpitations
  • contact dermatitis
  • gynecomastia
  • elevated prostate-specific antigen
  • allergic symptoms
  • ischemic necrosis
  • generalized edema
  • gastritis
  • hemorrhagic gastroenteritis
  • duodenal ulcer
  • gastric ulcer
  • perforated gastric ulcer
  • upper gastrointestinal ulcer bleeding
  • distension
  • hyperbilirubinemia
  • infectious hepatitis
  • fatty liver
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal hemorrhage
  • surgical wound hemorrhage
  • pulmonary hemorrhage
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • stomatitis
  • hepatitis
  • acute liver failure
  • herpes zoster
  • erythematous rash
  • papular urticaria
  • urticaria
  • renal dysfunction
  • acute renal failure
  • confusion
  • hallucination
  • taste alteration
  • taste loss
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • eczema
  • lichen planus
  • arthralgia
  • arthritis
  • myalgia
  • glomerulonephritis
  • fever
  • abnormal liver function tests
  • elevated blood creatinine
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.